BJDX on Nasdaq
Bluejay Diagnostics, Inc.
Price unavailable
Last updated Oct 16, 2026.
Overview
Compare with FAMILY OFFICE OF AMERICA, INC., QTREX Quantum Ltd. or Glucotrack, Inc., or pick any stock.
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2022
19.6%Gross margin3
-3741.5%Operating margin3
-3733.1%Net margin3
-80.6%Return on equity4
-$8.9MFree cash flow3
Where the money goes
Where each dollar of revenue went, fiscal 2022
- Cost of revenue4¢$200.1K
- Research and development86¢$4.2M
- Selling, general and admin9¢$451.4K
Out of $249.0K in revenue.3 The company lost money this year.
Financial statements
Every line of the income statement in the latest annual report, as filed.9
| Period ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Research and development | $3.0M | $3.5M |
| General and administrative | $3.9M | $3.7M |
| Sales and marketing | $8.3K | |
| Total operating expenses | $7.0M | $7.2M |
| Operating loss | -$7.0M | -$7.2M |
| Interest expense | -$839 | -$823.0K |
| Interest income | $97.6K | $145.8K |
| Other income, net | $7.8K | $129.0K |
| Total other income (expense), net | $104.5K | -$548.2K |
| Net loss | -$6.8M | -$7.7M |
| Deemed dividend on warrant modification | $13.2M | |
| Net loss applicable to common stockholders | -$6.8M | -$20.9M |
| Net Loss per share to common stockholders Basic (in Dollars per share) | -$15.25 | -$456.75 |
| Net Loss per share to common stockholders Diluted (in Dollars per share) | -$15.25 | -$456.75 |
| Weighted average common shares outstanding Basic (in Shares) | 449.0K shares | 45.8K shares |
| Weighted average common shares outstanding Diluted (in Shares) | 449.0K shares | 45.8K shares |
Every line of the balance sheet in the latest annual report, as filed.9
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Cash and cash equivalents | $5.2M | $4.3M | |
| Prepaid expenses and other current assets | $276.0K | $596.9K | |
| Assets held for sale | $22.8K | ||
| Total current assets | $5.5M | $4.9M | |
| Property and equipment, net | $1.5M | $1.5M | |
| Operating lease right-of-use assets | $113.3K | $209.8K | |
| Other non-current assets | $7.9K | $35.3K | |
| Total assets | $7.1M | $6.7M | |
| Accounts payable | $214.3K | $145.1K | |
| Operating lease liability, current | $100.0K | $113.3K | |
| Accrued expenses | $804.9K | $552.0K | |
| Total current liabilities | $1.1M | $810.4K | |
| Operating lease liability, non-current | $20.2K | $109.0K | |
| Other non-current liabilities | $4.5K | $8.6K | |
| Total liabilities | $1.1M | $927.9K | |
| Common stock, $0.0001 par value; 250,000,000 shares authorized; 604,534 and 138,503 shares issued and outstanding at December 31, 2025 and December 31, 2024, respectively | $60 | $14 | |
| Additional paid-in capital | $47.5M | $40.4M | |
| Accumulated deficit | -$41.5M | -$34.7M | |
| Total stockholders equity | $6.0M | $5.7M | $2.9M |
| Total liabilities and stockholders equity | $7.1M | $6.7M | |
| Common stock, par value (in Dollars per share) | $0.00 | $0.00 | |
| Common stock, shares authorized (in Shares) | 250.0M shares | 250.0M shares | |
| Common stock shares issued (in Shares) | 604.5K shares | 138.5K shares | |
| Common stock outstanding (in Shares) | 604.5K shares | 138.5K shares |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Every line of the cash flow in the latest annual report, as filed.9
| Period ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Net loss | -$6.8M | -$7.7M |
| Depreciation expense | $74.2K | $75.6K |
| Stock-based compensation expense | $6 | $20.1K |
| Amortization of right-of-use asset | $96.5K | $123.5K |
| Non-cash interest expense for note payable | $307.6K | |
| Write-off and impairment of property and equipment | $42.9K | $3.4K |
| Prepaid expenses and other current assets | $333.9K | $150.3K |
| Deferred offering costs | $265.1K | |
| Other non-current assets | $27.4K | -$6.6K |
| Accounts payable | $69.1K | -$346.4K |
| Accrued expenses and other current and non-current liabilities | $150.9K | -$695.7K |
| Net cash used in operating activities | -$6.1M | -$7.8M |
| Purchase of property and equipment | -$173.7K | -$306.8K |
| Net cash used in investing activities | -$173.7K | -$306.8K |
| Proceeds from issuance of common stock, gross | $8.3M | $12.1M |
| Payment for issuance costs of common stock | -$1.3M | -$1.8M |
| Proceeds from issuance of notes payable | $2.0M | |
| Repayment of notes payable | -$2.0M | |
| Proceeds from exercise of Class D warrants | $558 | |
| Fractional shares adjustment for reverse stock split | -$395 | |
| Payment of finance lease | -$4.0K | -$3.8K |
| Net cash provided by financing activities | $7.1M | $10.2M |
| Net increase in cash and cash equivalents | $862.9K | $2.1M |
| Fair value of common stock issued in connection with notes payable | $307.6K |
Recent filings
- Oct 13, 20268-K CURRENT REPORT
- Oct 6, 20268-K CURRENT REPORT
- Sep 8, 20268-K CURRENT REPORT
- Aug 18, 20264 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
- Aug 18, 20264 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
- Aug 18, 20264 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
- Aug 18, 20264 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
- Aug 18, 20264 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
- Aug 14, 2026SCHEDULE 13G
- Aug 13, 20268-K CURRENT REPORT
- Aug 13, 2026SCHEDULE 13G
- Aug 12, 202610-Q QUARTERLY REPORT
- Aug 12, 2026S-8 REGISTRATION STATEMENT
- Jul 22, 20263 PRIMARY DOCUMENT
- Jul 22, 20264 PRIMARY DOCUMENT
Every filing from the last three years, summarized. The full record is on SEC EDGAR.1
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9